High Intra- and Inter-block concordance of HER2 immunohistochemistry (IHC) scores across breast cancer samples and impact of decalcification procedures

被引:0
|
作者
Tsirka, Asimina
Garrido, Charo
Scott, Marietta
Scorer, Paul
Boothman, Anne-Marie
Matsuo, Tsuyoshi
Barker, Craig
机构
关键词
D O I
10.1158/1538-7445.SABCS22-P6-04-17
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P6-04-17
引用
收藏
页数:2
相关论文
共 26 条
  • [21] GeneXpert® breast cancer STRAT4 assay demonstrates high concordance of ESR1, PgR, HER2, and Ki67 with central IHC and FISH testing in FFPE breast tumor tissues
    Wong, E.
    Wu, N.
    Acca, B.
    Dias, H.
    Quigley, N.
    Beqaj, S. S.
    David, K.
    Davenport, S.
    Press, M.
    BREAST, 2017, 32 : S49 - S49
  • [22] Concordance and clinical impact of ER, PR, HER2 expression by local and central immunohistochemistry versus RT-PCR in HR+/HER2-early breast cancer (EBC): Results from the ADAPT trial.
    Gluz, Oleg
    Christgen, Matthias
    Kuemmel, Sherko
    Eulenburg, Christine Zu
    Braun, Michael
    Aktas, Bahriye
    Luedtke-Heckenkamp, Kerstin
    Forstbauer, Helmut
    Grischke, Eva-Maria
    Schumacher, Claudia
    Krauss, Katja
    Thill, Marc
    Warm, Mathias
    Graeser, Monika Karla
    Wuerstlein, Rachel
    Kates, Ronald E.
    Baehner, Frederick L.
    Nitz, Ulrike
    Kreipe, Hans Heinrich
    Harbeck, Nadia
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [23] Impact of Original FDA and New ASCO/CAP Guidelines for HER2/neu Evaluation in Breast Cancer: IHC and FISH scores using Manual or Quantitative-Automated Imaging Systems and Different Fixatives
    Hutchinson, L.
    St Cyr, M.
    Garver, J.
    McCormick, I.
    Cosar, E. F.
    Savas, L.
    Meola, F.
    Goddard, L.
    Smith, K.
    Scott, M.
    Fischer, A.
    Prasad, M.
    Khan, A.
    Woda, B.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 604 - 604
  • [24] Concordance/discordance rates of HER2, ER, PR, and Ki67 in matched pair samples of primary (PBC) and metastatic breast cancer (MBC) tissues when comparing IHC with MammaTyper® RT-PCR kit
    Wallwiener, Markus
    Hartkopf, Andreas
    Deutsch, Thomas
    Sotiris, Lakis
    Taran, Florin-Andrei
    Trumpp, Andreas
    Wirtz, Ralph
    Schneeweiss, Andreas
    CANCER RESEARCH, 2015, 75
  • [25] Attainment of extremely high concordance rates between fluorescence in situ hybridization and immunohistochemistry in testing for human epidermal growth factor receptor 2 (HER2) in breast cancer using a normalized scoring system for immunohistochemistry: a four year experience with over 9000 cases
    Gown, A. M.
    Goldstein, L. C.
    Tse, C. H.
    Hwang, H. C.
    Kandalaft, P. L.
    CANCER RESEARCH, 2012, 72
  • [26] Reassignment of HER2 status for subgroups of breast cancer according to the 2018 updated American Society of Clinical Oncology and College of American Pathologists guidelines: The impact of combined immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) reflex testing in a large national reference laboratory.
    Geiersbach, Katherine
    Meyer, Reid G.
    Kloft-Nelson, Sara M.
    Knutson, Darlene L.
    Knudson, Ryan A.
    Sukov, William R.
    Ketterling, Rhett P.
    Greipp, Patricia T.
    Jenkins, Robert B.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)